New developments on actinomyces CRISPR tools by Tong, Yaojun
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Mar 30, 2019
New developments on actinomyces CRISPR tools
Tong, Yaojun
Publication date:
2017
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Tong, Y. (2017). New developments on actinomyces CRISPR tools. Abstract from DTU Biosustain Annual
Seminar 2017, Elsinore, Denmark.
*Corresponding author: tiwe@biosustain.dtu.dk, or leesy@kaist.ac.kr 
 
New developments on actinomyces CRISPR tools 
 
Yaojun Tong1, Helene L. Robertsen1, Kai Blin1, Tilmann Weber1,*, and Sang Yup Lee1,2,* 
1The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kgs. Lyngby, 
Denmark 
2Metabolic and Biomolecular Engineering National Research Laboratory, Department of Chemical and Biomolecular 
Engineering (BK21 Plus Program), Center for Systems and Synthetic Biotechnology, Institute for the BioCentury, 
Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea 
*E-mail: tiwe@biosustain.dtu.dk, or leesy@kaist.ac.kr 
  
 
Keywords: CRISPR-Cas9, actinomycetes, sgRNA finder, DNA free genome editing, multiplex sgRNA
 
Actinomycetes are one of the most important sources of pharmacological and industrial relevant 
natural products (Weber, T., et al, 2015). Unfortunately, many of the wild-type strains are recalcitrant 
to efficient genetic manipulation approaches, which is a severe bottleneck for systematic metabolic 
engineering. We developed a genome editing toolkit based on CRISPR-Cas9, which includes three 
sub-systems, pCRISPR-Cas9, pCRISPR-Cas9-ScaligD, and pCRISPR-dCas9 (CRISPRi), for 
genome editing and modulating transcription of target genes (Tong, Y., et al, 2015; Tong, Y., et al, 
2016). The system is widely used in our section and the actinomycete community. Although the 
toolkit significantly speeds up genetic engineering for many strains, there are still limitations: for 
instance, often non-model actinomycetes cannot be transformed using the standard protocols, are 
resistant to the standard antibiotics used for plasmid selection, or cannot replicate commonly used 
plasmids; there is no very good spacer finder for non-model organisms; the current system cannot 
meet the high throughput and automation genome editing purpose. In order to address these 
limitations, we extended our actinomycete CRISPR-Cas9 toolkit: a spacer finder, CRISPy-web (Blin, 
K., et al, 2016) was released to facilitate the sgRNA design for non-model organisms, which can 
design sgRNAs for any microbial genome. A prototype of a “DNA-free” genome editing system for 
actinomycetes was demonstrated by inactivating actinorhodin production in the model strain S. 
coelicolor. An USER-based multiple sgRNA assembly strategy (Tong, Y., et al, 2017) was developed 
and validated for automated high-throughput cloning. This update of our CRISPR-Cas9 toolkit will 
further extended its applicability for actinomycetal genome editing. 
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